POWERS; Jay
Patent Applications and Registrations
Patent applications and USPTO patent grants for POWERS; Jay.The latest application filed is for "substituted anilines as ccr(4) antagonists".
Company Profile
13.32.39
- POWERS; Jay - Pacifica CA
- Powers; Jay - Pacific CA
Patent Activity
| Patent | Date |
|---|---|
| Substituted Anilines As Ccr(4) Antagonists App 20220194929 - CHARVAT; Trevor T. ; et al. | 2022-06-23 |
| Azolopyrimidine For The Treatment Of Cancer-related Disorders App 20220144808 - BEATTY; Joel ; et al. | 2022-05-12 |
| Substituted anilines as CCR(4) antagonists Grant 11,142,521 - Charvat , et al. October 12, 2 | 2021-10-12 |
| C5ar Antagonists App 20210269398 - Fan; Pingchen ; et al. | 2021-09-02 |
| Azolopyrimidine for the treatment of cancer-related disorders Grant 11,072,597 - Beatty , et al. July 27, 2 | 2021-07-27 |
| Azolopyrimidine For The Treatment Of Cancer-related Disorders App 20210101880 - BEATTY; Joel ; et al. | 2021-04-08 |
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS App 20200354320 - FAN; Pingchen ; et al. | 2020-11-12 |
| C5aR antagonists Grant 10,660,897 - Fan , et al. | 2020-05-26 |
| Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists Grant 10,647,696 - Leleti , et al. | 2020-05-12 |
| Substituted Anilines As Ccr(4) Antagonists App 20200123139 - CHARVAT; Trevor T. ; et al. | 2020-04-23 |
| Processes and intermediates in the preparation of C5aR antagonists Grant 10,532,982 - Fan , et al. Ja | 2020-01-14 |
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS App 20190276402 - FAN; Pingchen ; et al. | 2019-09-12 |
| Substituted anilines as CCR(4) antagonists Grant 10,407,417 - Charvat , et al. Sept | 2019-09-10 |
| Azolopyrimidine for the treatment of cancer-related disorders Grant 10,399,962 - Beatty , et al. Sep | 2019-09-03 |
| Processes and intermediates in the preparation of C5aR antagonists Grant 10,266,492 - Fan , et al. | 2019-04-23 |
| C5aR ANTAGONISTS App 20190060321 - FAN; Pingchen ; et al. | 2019-02-28 |
| C5aR ANTAGONISTS App 20190062275 - FAN; Pingchen ; et al. | 2019-02-28 |
| Azolopyrimidine For The Treatment Of Cancer-related Disorders App 20180215730 - BEATTY; Joel ; et al. | 2018-08-02 |
| C5aR antagonists Grant 10,035,768 - Fan , et al. July 31, 2 | 2018-07-31 |
| C5ar Antagonists App 20180179160 - FAN; Pingchen ; et al. | 2018-06-28 |
| Substituted Anilines As Ccr(4) Antagonists App 20180162846 - CHARVAT; Trevor T. ; et al. | 2018-06-14 |
| Substituted Benzimidazoles And Benzopyrazoles As Ccr(4) Antagonists App 20180127395 - LELETI; Manmohan Reddy ; et al. | 2018-05-10 |
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS App 20180072668 - FAN; Pingchen ; et al. | 2018-03-15 |
| Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists Grant 9,790,204 - Leleti , et al. October 17, 2 | 2017-10-17 |
| Substituted anilines as CCR(4) antagonists Grant 9,758,512 - Charvat , et al. September 12, 2 | 2017-09-12 |
| Processes and intermediates in the preparation of C5aR antagonists Grant 9,745,268 - Fan , et al. August 29, 2 | 2017-08-29 |
| C5ar Antagonists App 20170114017 - FAN; Pingchen ; et al. | 2017-04-27 |
| C5aR ANTAGONISTS App 20170065604 - FAN; Pingchen ; et al. | 2017-03-09 |
| C5AR antagonists Grant 9,573,897 - Fan , et al. February 21, 2 | 2017-02-21 |
| Substituted anilines as CCR(4) antagonists Grant 9,567,323 - Charvat , et al. February 14, 2 | 2017-02-14 |
| Substituted Anilines As Ccr(4) Antagonists App 20160317545 - Charvat; Trevor T. ; et al. | 2016-11-03 |
| C5ar Antagonists App 20160229802 - FAN; Pingchen ; et al. | 2016-08-11 |
| N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides Grant 9,409,909 - Charvat , et al. August 9, 2 | 2016-08-09 |
| Substituted Benzimidazoles And Benzopyrazoles As Ccr(4) Antagonists App 20160185756 - LELETI; Manmohan Reddy ; et al. | 2016-06-30 |
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS App 20160090357 - FAN; Pingchen ; et al. | 2016-03-31 |
| Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists Grant 9,150,550 - Leleti , et al. October 6, 2 | 2015-10-06 |
| C5AR antagonists Grant 9,126,939 - Fan , et al. September 8, 2 | 2015-09-08 |
| Substituted Anilines As Ccr(4) Antagonists App 20150141397 - Charvat; Trevor T. ; et al. | 2015-05-21 |
| C5aR ANTAGONISTS App 20150141425 - Fan; Pingchen ; et al. | 2015-05-21 |
| N-(2-(hetaryl)aryl)arylsulfonamides And N-(2-(hetaryl)hetaryl)arylsulfonamides App 20150018337 - Charvat; Trevor T. ; et al. | 2015-01-15 |
| Modulators of CXCR7 Grant 8,853,202 - Chen , et al. October 7, 2 | 2014-10-07 |
| N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides Grant 8,835,468 - Charvat , et al. September 16, 2 | 2014-09-16 |
| Substituted anilines as CCR(4) antagonists Grant 8,835,419 - Charvat , et al. September 16, 2 | 2014-09-16 |
| Substituted Benzimidazoles And Benzopyrazoles As Ccr(4) Antagonists App 20140121195 - Leleti; Manmohan Reddy ; et al. | 2014-05-01 |
| Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists Grant 8,685,959 - Leleti , et al. April 1, 2 | 2014-04-01 |
| C5aR ANTAGONISTS App 20130317028 - Fan; Pingchen ; et al. | 2013-11-28 |
| Substituted Anilines As Ccr(4) Antagonists App 20130172315 - Charvat; Trevor T. ; et al. | 2013-07-04 |
| C5ar Antagonists App 20130172347 - Fan; Pingchen ; et al. | 2013-07-04 |
| Substituted Benzimidazoles And Benzopyrazoles As Ccr(4) Antagonists App 20130165423 - Leleti; Manmohan Reddy ; et al. | 2013-06-27 |
| C5aR antagonists Grant 8,445,515 - Fan , et al. May 21, 2 | 2013-05-21 |
| Modulators of CXCR7 Grant 8,288,373 - Chen , et al. October 16, 2 | 2012-10-16 |
| N-(2-(hetaryl)aryl)arylsulfonamides And N-(2-(hetaryl)hetaryl Arylsulfonamides App 20120245138 - Charvat; Trevor T. ; et al. | 2012-09-27 |
| N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides Grant 8,198,309 - Charvat , et al. June 12, 2 | 2012-06-12 |
| Phthalazine compounds, compositions and methods of use Grant 8,153,633 - Austin , et al. April 10, 2 | 2012-04-10 |
| N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases Grant 7,932,421 - Yuan , et al. April 26, 2 | 2011-04-26 |
| Modulators Of Cxcr7 App 20110014121 - Chen; Xi ; et al. | 2011-01-20 |
| N-(2-(hetaryl)aryl) Arylsulfonamides And N-(2-(hetaryl)hetaryl Arylsulfonamides App 20100331302 - Charvat; Trevor T. ; et al. | 2010-12-30 |
| Modulators Of Cxcr7 App 20100311712 - CHEN; Xi ; et al. | 2010-12-09 |
| N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides Grant 7,776,877 - Charvat , et al. August 17, 2 | 2010-08-17 |
| C5aR ANTAGONISTS App 20100160320 - Fan; Pingchen ; et al. | 2010-06-24 |
| Modulators Of Cxcr7 App 20100150831 - Chen; Xi ; et al. | 2010-06-17 |
| Phthalazine compounds, compositions and methods of use App 20090048259 - Austin; Richard J. ; et al. | 2009-02-19 |
| N-(2-(hetaryl)aryl) Arylsulfonamides And N-(2-(hetaryl) Hetaryl Arylsulfonamides App 20090005410 - Charvat; Trevor T. ; et al. | 2009-01-01 |
| N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases App 20080221175 - Yuan; Chester Chenguang ; et al. | 2008-09-11 |
| Inflammation modulators Grant 7,176,314 - Cushing , et al. February 13, 2 | 2007-02-13 |
| Inflammation modulators App 20030181472 - Clark, David L. ; et al. | 2003-09-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 